Hydrogel News and Research

RSS

Tips to prevent foot injuries from high heel shoes

High heels, offer a height advantage to shorter women and can also make the calves and legs appear shapelier...but that’s where the benefits end. Most women sooner or later, develop a love/hate relationship with their collection of shoes, that is to say they are often attractive yet painful to wear. As we approach the Christmas party season ‘what shoes to wear’ can become a real concern.

9 Dec 2009

Positive data from Provectus Pharmaceuticals' psoriasis and atopic dermatitis trials

Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced preliminary data for the company’s PH-10 Phase 2 clinical trial for Psoriasis as well as for its Phase 2 clinical trial for Atopic Dermatitis.

1 Dec 2009

Silicone Hydrogel contact lens outperfoms in Malaysian market, premium price not a deterrent

Retail sales of contact lenses within the West Coast of Malaysia grew steadily in the first half of 2009 with total consumption peaking in June, driven by improving consumer sentiment and aggressive promotions from major Contact Lens manufacturers. Positive sales data showing a growth of 14% from January 2009 ending August further cemented the view of an economic recovery that is being led by consumers spending.

16 Nov 2009

Contact lenses prescribed for longer replacement intervals can lead to undesirable clinical outcomes

Contact lenses prescribed for longer replacement intervals can lead to more extreme over wear (stretching) that could lead to undesirable clinical effects, new research shows.

12 Nov 2009

LecTec settles patent litigation dispute with Endo Pharmaceuticals

LecTec Corporation (OTCBB: LECT) announced today that it has reached a settlement with Endo Pharmaceuticals Inc. on outstanding patent litigation related to LecTec’s U.S. Patent Nos. 5,536,263 and 5,741,510. Endo Pharmaceuticals has agreed to make a one–time, $23 million payment for the exclusive license to these two patents for use in the field of prescription pain medicines and treatment.

12 Nov 2009

FDA-approved DuraSeal spine sealant from Covidien

Covidien, a leading global provider of healthcare products, today announced the launch of DuraSeal™ spine sealant, the first product approved by the U.S. Food and Drug Administration (FDA) for intra-operative sealing of the dural membrane during spine procedures.

11 Nov 2009

Ocutec receives CE Mark approval for its first PEG hydrogel-based contact lens product

Ocutec Ltd, the medical devices specialist today announced at the American Academy of Optometry Meeting in Orlando CE Mark approval for its first poly(ethylene )glycol (PEG) hydrogel-based contact lens product. In initial patient acceptance trials, this next generation of lenses has demonstrated superior oxygen permeability compared to existing hydrogel based lenses.

11 Nov 2009

New improved enzyme could help facilitate spinal cord injuries

Researchers have developed an improved version of an enzyme that degrades the dense scar tissue that forms when the central nervous system is damaged. By digesting the tissue that blocks re-growth of damaged nerves, the improved enzyme - and new system for delivering it - could facilitate recovery from serious central nervous system injuries.

4 Nov 2009

Optics industry reinventing itself through personalized service logistics solutions

GfK Asia releases its Pan Asia optical retailers and consumers preference survey information in line with the 17th Hong Kong Optical Fair, hosted by Hong Kong Trade Development Council. The five key regions surveyed in October 2009 include China, Hong Kong, Korea, Singapore and Malaysia. The survey shows that 70% of optical retailers indicate business will be better or the same in 2010.

2 Nov 2009

CeloNova BioSciences submits a request for approval of its new Embozene Microsphere

CeloNova BioSciences today announced that the company is submitting to its European Notified Body a request for approval of its new, lime green, 2800 micron size Embozene(TM) Microsphere.

31 Oct 2009

CryoLife reports a net income of $1.9 million for the third quarter of 2009

CryoLife, Inc., an implantable biological medical device and cardiovascular tissue processing company, announced today that revenues for the third quarter of 2009 increased 5 percent to a quarterly record of $28.2 million compared to $26.8 million for the third quarter of 2008.

29 Oct 2009

CryoLife granted FDA approval for BioFoam human clinical trial

CryoLife, Inc., an implantable biological medical device and cardiovascular tissue processing company, today announced that the U.S. Food and Drug Administration (FDA) has granted approval for the company's Investigational Device Exemption (IDE) to conduct a human clinical trial for its BioFoam® Surgical Matrix protein hydrogel technology.

27 Oct 2009

Assets of Cartilix acquired by Biomet

Biomet, Inc., a global leader in the manufacture of orthopedic and dental medical devices, announced today its acquisition of the assets of Cartilix, a Foster City, CA based company that has developed proprietary cartilage repair technology.

21 Oct 2009

New 3D scaffolding technology may help grow skin and blood vessels in labs

Scientists are developing new scaffolding technology which could be used to grow tissues such as skin, nerves and cartilage using 3D spaghetti-like structures. Their research is highlighted in the latest issue of Business, the quarterly highlights magazine of the Biotechnology and Biological Sciences Research Council (BBSRC).

19 Oct 2009

CeloNova BioSciences' Embozene Microspheres receives approval

CeloNova BioSciences, Inc. has received approval from its European regulatory body, the British Standards Institution, to expand the list of medical indications for which Embozene(TM) Microspheres may be used and to add a tenth size of the product.

14 Oct 2009

HyperBranch Medical Technology's NuSeal 30 hernia mesh fixation sealant product receives CE Mark

HyperBranch Medical Technology, Inc. announced today that it has received a CE Mark for its NuSeal 30 hernia mesh fixation sealant product. NuSeal 30 is used in hernia procedures to adhere the mesh. NuSeal 30 provides for secure mesh placement, minimizes pain caused by other fixation devices and gradually degrades as the body heals.

13 Oct 2009

Systagenix Wound Management forms new global Medical Advisory Board

Systagenix Wound Management has announced the formation of a new global Medical Advisory Board, consisting of a group of multi-disciplinary and highly respected wound care clinicians and practitioners from North America and Europe, which will be led by Systagenix's newly appointed Medical Director, Dr Robert Snyder.

13 Oct 2009

Provectus Pharmaceuticals completes initial treatment in Phase 2 trial of PH-10 for plaque psoriasis

Provectus Pharmaceuticals, Inc., a development stage oncology and dermatology biopharmaceutical company, has completed patient accrual and initial treatment in its Phase 2 trial of PH-10 for the treatment of plaque psoriasis. This milestone marks the third Phase 2 clinical trial for which Provectus has completed patient accrual since May 2009.

13 Oct 2009

New embolization technique offers better clinical outcomes in the treatment of liver cancer

The authors of a newly published paper in the September/October journal Vascular Disease Management conclude that the micro-bland embolization technique possible with Embozene(TM) Color-Advanced Microspheres leads to better clinical outcomes.

6 Oct 2009

ARRA stimulus funds fuel research projects across America

The Association of American Universities (AAU), the Association of Public and Land-grant Universities (APLU), and The Science Coalition (TSC) today released highlighted examples of the important scientific work happening across the country as a result of the American Recovery and Reinvestment Act of 2009 (ARRA). The brief report summarizes just a handful of the thousands of projects benefiting from stimulus dollars.

30 Sep 2009

Hydrogel News and Research

Tips to prevent foot injuries from high heel shoes

Positive data from Provectus Pharmaceuticals' psoriasis and atopic dermatitis trials

Silicone Hydrogel contact lens outperfoms in Malaysian market, premium price not a deterrent

Contact lenses prescribed for longer replacement intervals can lead to undesirable clinical outcomes

LecTec settles patent litigation dispute with Endo Pharmaceuticals

FDA-approved DuraSeal spine sealant from Covidien

Ocutec receives CE Mark approval for its first PEG hydrogel-based contact lens product

New improved enzyme could help facilitate spinal cord injuries

Optics industry reinventing itself through personalized service logistics solutions

CeloNova BioSciences submits a request for approval of its new Embozene Microsphere

CryoLife reports a net income of $1.9 million for the third quarter of 2009

CryoLife granted FDA approval for BioFoam human clinical trial

Assets of Cartilix acquired by Biomet

New 3D scaffolding technology may help grow skin and blood vessels in labs

CeloNova BioSciences' Embozene Microspheres receives approval

HyperBranch Medical Technology's NuSeal 30 hernia mesh fixation sealant product receives CE Mark

Systagenix Wound Management forms new global Medical Advisory Board

Provectus Pharmaceuticals completes initial treatment in Phase 2 trial of PH-10 for plaque psoriasis

New embolization technique offers better clinical outcomes in the treatment of liver cancer

ARRA stimulus funds fuel research projects across America

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News